National Heart, Lung, and Blood Institute; Notice of Closed Meetings

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published

February 4, 2022

Issuing agencies

Health and Human Services DepartmentNational Institutes of Health

Full Text

<html>
<head>
<title>Federal Register, Volume 87 Issue 24 (Friday, February 4, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 24 (Friday, February 4, 2022)]
[Notices]
[Page 6615]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-02333]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Clinical Trials SEP (UG3, U24, R61, R34).
    Date: March 10, 2022.
    Time: 11:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6705 Rockledge Drive, 
Bethesda, MD 20817 (Virtual Meeting).
    Contact Person: Zhihong Shan, MD, Ph.D., Scientific Review 
Officer, Office of Scientific Review/DERA, National Heart, Lung, and 
Blood Institute, National Institutes of Health, 6705 Rockledge 
Drive, Room 205-J, Bethesda, MD 20892, (301) 827-7085, 
<a href="/cdn-cgi/l/email-protection#93e9fbfafbfcfdf4bde0fbf2fdd3fdfafbbdf4fce5"><span class="__cf_email__" data-cfemail="acd6c4c5c4c3c2cb82dfc4cdc2ecc2c5c482cbc3da">[email&#160;protected]</span></a>.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Regenerative Medicine Innovation Project 
Review.
    Date: March 11, 2022.
    Time: 1:00 p.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6705 Rockledge Drive, 
Bethesda, MD 20817 (Virtual Meeting).
    Contact Person: Michael P. Reilly, Ph.D., Scientific Review 
Officer, Office of Scientific Review/DERA, National Heart, Lung, and 
Blood Institute, National Institutes of Health, 6705 Rockledge 
Drive, Room 208-Z, Bethesda, MD 20892, (301) 827-7975, 
<a href="/cdn-cgi/l/email-protection#d1a3b4b8bdbda8bca191bfb9bdb3b8ffbfb8b9ffb6bea7"><span class="__cf_email__" data-cfemail="6715020e0b0b1e0a1727090f0b050e49090e0f49000811">[email&#160;protected]</span></a>.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Understanding and Reducing Cardiovascular 
Disease in Type 1 Diabetes Mellitus.
    Date: March 30, 2022.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6705 Rockledge Drive, 
Bethesda, MD 20817 (Virtual Meeting).
    Contact Person: Susan Wohler Sunnarborg, Ph.D., Scientific 
Review Officer, Office of Scientific Review/DERA, National, Heart, 
Lung, and Blood Institute, National Institutes of Health, 6705 
Rockledge Drive, Room 208-Z, Bethesda, MD 20892, (301) 827-7987, 
<a href="/cdn-cgi/l/email-protection#85f6f0f6e4ebabf6f0ebebe4f7e7eaf7e2c5ebecedabe2eaf3"><span class="__cf_email__" data-cfemail="d8abadabb9b6f6abadb6b6b9aabab7aabf98b6b1b0f6bfb7ae">[email&#160;protected]</span></a>.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Stimulating Access to Research in Residency 
Transition Scholar.
    Date: March 30, 2022.
    Time: 1:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6705 Rockledge Drive, 
Bethesda, MD 20817 (Virtual Meeting).
    Contact Person: Zhihong Shan, MD, Ph.D., Scientific Review 
Officer, Office of Scientific Review/DERA, National Heart, Lung, and 
Blood Institute, National Institutes of Health, 6705 Rockledge 
Drive, Room 205-J, Bethesda, MD 20892, (301) 827-7085, 
<a href="/cdn-cgi/l/email-protection#82f8eaebeaedece5acf1eae3ecc2ecebeaace5edf4"><span class="__cf_email__" data-cfemail="91ebf9f8f9fefff6bfe2f9f0ffd1fff8f9bff6fee7">[email&#160;protected]</span></a>.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Syndemics of HLBS Diseases and HIV.
    Date: March 31, 2022.
    Time: 9:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6705 Rockledge Drive, 
Bethesda, MD 20817 (Virtual Meeting).
    Contact Person: Shelley Sehnert, Ph.D., Scientific Review 
Officer, Office of Scientific Review/DERA, National Heart, Lung, and 
Blood Institute, National Institutes of Health, 6705 Rockledge 
Drive, Suite 208-T, Bethesda, MD 20817, (301) 827-7984, 
<a href="/cdn-cgi/l/email-protection#e1929284898f849395a18f898d8388cf8f8889cf868e97"><span class="__cf_email__" data-cfemail="c8bbbbada0a6adbabc88a6a0a4aaa1e6a6a1a0e6afa7be">[email&#160;protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: January 31, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-02333 Filed 2-3-22; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>

View on FederalRegister.gov →Plain-text source

Indexed from Federal Register on February 4, 2022.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.